MANNKIND CORP — Director's Dealing 2019

Feb 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MANNKIND CORP (MNKD)
CIK: 0000899460
Period of Report: 2019-02-20

Reporting Person: Kendall David M (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-20	Restricted Stock Unit	A	37026	$0.00	Acquired	44850	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of MNKD common stock.

F2: Restricted stock units shall vest and be delivered on February 20, 2020.